Sanofi’s updated fair value price target of €98.49 is unchanged, indicating that analysts have kept their core valuation anchor steady. Much of the current debate focuses on how comfortably this ...

Reports full year revenues of $563.8 million and Adjusted EBITDAS of $30.6 millionCALGARY, Alberta, March 10, 2026 (GLOBE NEWSWIRE) -- FLINT Corp. (“FLINT” or the "Company") (TSX: FLNT) today ...